Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

Clinical trial NCT00635414 · COMPLETED

Trial details

NCT number: NCT00635414
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Start date: 2002-08-01
Primary completion: 2002-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.